Patent Grant
11022815
Embodiments of the present invention relate to vision treatment techniques and in particular, to ophthalmic lenses such as, for example, contact lenses, corneal inlays or onlays, or intraocular lenses (IOLs) including, for example, phakic IOLs and piggyback IOLs (i.e. IOLs implanted in an eye already having an IOL).
Presbyopia is a condition that affects the accommodation properties of the eye. As objects move closer to a young, properly functioning eye, the effects of ciliary muscle contraction and zonular relaxation allow the lens of the eye to change shape, and thus increase its optical power and ability to focus at near distances. This accommodation can allow the eye to focus and refocus between near and far objects.
Presbyopia normally develops as a person ages, and is associated with a natural progressive loss of accommodation. The presbyopic eye often loses the ability to rapidly and easily refocus on objects at varying distances. The effects of presbyopia usually become noticeable after the age of 45 years. By the age of 65 years, the crystalline lens has often lost almost all elastic properties and has only limited ability to change shape.
Along with reductions in accommodation of the eye, age may also induce clouding of the lens due to the formation of a cataract. A cataract may form in the hard central nucleus of the lens, in the softer peripheral cortical portion of the lens, or at the back of the lens. Cataracts can be treated by the replacement of the cloudy natural lens with an artificial lens. An artificial lens replaces the natural lens in the eye, with the artificial lens often being referred to as an intraocular lens or “IOL”.
Monofocal IOLs are intended to provide vision correction at one distance only, usually the far focus. Predicting the most appropriate IOL power for implantation has limited accuracy, and an inappropriate IOL power can leave patients with residual refraction following surgery. Accordingly, it may be necessary for a patient who has received an IOL implant to also wear spectacles to achieve good far vision. At the very least, since a monofocal IOL provides vision treatment at only one distance and since the typical correction is for far distance, spectacles are usually needed for good near vision and sometimes intermediate vision. The term “near vision” generally corresponds to vision provided when objects are at a distance from the subject eye of between about 1 to 2 feet are substantially in focus on the retina of the eye. The term “distant vision” generally corresponds to vision provided when objects at a distance of at least about 6 feet or greater are substantially in focus on the retina of the eye. The term “intermediate vision” corresponds to vision provided when objects at a distance of about 2 feet to about 5 feet from the subject eye are substantially in focus on the retina of the eye.
There have been various attempts to address limitations associated with monofocal IOLs. For example, multifocal IOLs have been proposed that deliver, in principle, two foci, one near and one far, optionally with some degree of intermediate focus. Such multifocal or bifocal IOLs are intended to provide good vision at two distances, and include both refractive and diffractive multifocal IOLs. In some instances, a multifocal IOL intended to correct vision at two distances may provide a near add power of about 3.0 or 4.0 Diopters.
Multifocal IOLs may, for example, rely on a diffractive optical surface to direct portions of the light energy toward differing focal distances, thereby allowing the patient to clearly see both near and far objects. Multifocal ophthalmic lenses (including contact lenses or the like) have also been proposed for treatment of presbyopia without removal of the natural crystalline lens. Diffractive optical surfaces, either monofocal or multifocal, may also be configured to provide reduced chromatic aberration.
Diffractive monofocal and multifocal lenses can make use of a material having a given refractive index and a surface curvature which provide a refractive power. Diffractive lenses have a diffractive profile which confers the lens with a diffractive power that contributes to the overall optical power of the lens. The diffractive profile is typically characterized by a number of diffractive zones. When used for ophthalmic lenses these zones are typically annular lens zones, or echelettes, spaced about the optical axis of the lens. Each echelette may be defined by an optical zone, a transition zone between the optical zone and an optical zone of an adjacent echelette, and an echelette geometry. The echelette geometry includes an inner and outer diameter and a shape or slope of the optical zone, a height or step height, and a shape of the transition zone. The surface area or diameter of the echelettes largely determines the diffractive power(s) of the lens and the step height of the transition between echelettes largely determines the light distribution between the different add powers. Together, these echelettes form a diffractive profile.
A multifocal diffractive profile of the lens may be used to mitigate presbyopia by providing two or more optical powers; for example, one for near vision and one for far vision. The lenses may also take the form of an intraocular lens placed within the capsular bag of the eye, replacing the original lens, or placed in front of the natural crystalline lens. The lenses may be in the form of a contact lens, most commonly a bifocal contact lens, or in any other form mentioned herein.
Although multifocal ophthalmic lenses lead to improved quality of vision for many patients, additional improvements would be beneficial. For example, some pseudophakic patients experience undesirable visual effects (dysphotopsia), e.g. glare or halos. Halos may arise when light from the unused focal image creates an out-of-focus image that is superimposed on the used focal image. For example, if light from a distant point source is imaged onto the retina by the distant focus of a bifocal IOL, the near focus of the IOL will simultaneously superimpose a defocused image on top of the image formed by the distant focus. This defocused image may manifest itself in the form of a ring of light surrounding the in-focus image, and is referred to as a halo. Another area of improvement revolves around the typical bifocality of multifocal lenses. Since multifocal ophthalmic lenses typically provide for near and far vision, intermediate vision may be compromised.
A lens with an extended depth of focus may provide certain patients the benefits of good vision at a range of distances, while having reduced or no dysphotopsia. Various techniques for extending the depth of focus of an IOL have been proposed. For example, some approaches are based on a bulls-eye refractive principle, and involve a central zone with a slightly increased power. Other techniques include an asphere or include refractive zones with different refractive zonal powers.
Although certain proposed treatments may provide some benefit to patients in need thereof, still further advances would be desirable. For example, it would be desirable to provide improved IOL systems and methods that confer enhanced image quality across a wide and extended range of foci without dysphotopsia. Embodiments of the present invention provide solutions that address the problems described above, and hence provide answers to at least some of these outstanding needs.
Embodiments of the present invention generally provide improved lenses and imaging techniques. Exemplary embodiments provide improved ophthalmic lenses (such as, for example, contact lenses, corneal inlays or onlays, or intraocular lenses (IOLs) including, for example, phakic IOLs and piggyback IOLs) and associated methods for their design and use.
Embodiments of the present invention encompass IOL optics having a circular surface structure with one to four echelettes surrounding the surface structure. The profile is designed such that it increases the depth of focus of the pseudophakic eye, where the natural crystalline lens of the eye is substituted with a synthetic lens. Such limited ring IOL techniques suppress the distinct bifocality associated with traditional multifocal IOLs which have many diffractive rings. Consequently, dysphotopsia (e.g., halo effects) associated with traditional multifocal IOLs can be alleviated by lenses according to embodiments of the present invention.
An exemplary limited ring IOL includes an anterior face and a posterior face. A profile can be imposed on the anterior or posterior surface or face. The profile can have an inner portion and an outer portion. The inner portion typically presents a parabolic curved shape. The inner portion may also be referred to as a microstructure, or a central or inner echelette. Between the inner portion and the outer portion, there may be a transition zone that connects the inner and outer portions. The outer portion may be comprised of four or fewer echelettes.
In addition to parabolic shapes, the central/inner echelette can have any of a variety of shapes including hyperbolic, spherical, aspheric, and sinusoidal. The transition between the inner and outer portions of the central/inner echelette can be a sharp transition, or it can be a smooth transition.
The surface of the outer portion at the outside of the microstructure can have any spherical or aspherical shape and is comprised of a limited number of echelettes, preferably less than four. The shape of the outer portion can be optimized for having the desired optical performance for a range of pupil sizes. The desired optical performance can be based on elements such as the depth of focus, the optical quality in the far focus, and the change in best focus (or far focus) position as a function of the pupil size. Optimization rules may be applied as if the shape were a refractive monofocal IOL, or a refractive IOL having an extended depth of focus, or a refractive design that corrects or modifies the ocular spherical aberration. Specific designs can be made in which the interplay between the central echelette and the outer zone is incorporated in the design or optimization. The techniques described herein are well suited for implementation with any of a variety of ophthalmic lenses, including IOLs, corneal inlays or onlays, and/or contact lenses.
In one aspect, embodiments of the present invention encompass ophthalmic lens systems and methods for treating an eye of a patient. An exemplary lens may include an anterior face with an anterior refractive profile and a posterior face with a posterior refractive profile. The faces may be disposed about an optical axis. The lens may also include a diffractive profile imposed on the anterior refractive profile or the posterior refractive profile. In some cases, the diffractive profile may include no more than 5 echelettes. Optionally, the central echelette can be disposed within a central zone of the lens. Relatedly, the central echelette may be disposed within an annular ring surrounding a central refractive zone of the lens. In some cases, the lens includes a peripheral zone with a limited number of echelettes that surround the central echelette or annular ring. The limited number of echelettes may be characterized by a constant phase shift.
According to some embodiments, an ophthalmic lens can include a limited number of echelettes that are characterized by parabolic curves. The central echelette can have a diameter within a range from about 1 mm to about 4 mm. For example, the central echelette may have a diameter of about 1.5 mm. In some cases, the central echelette can have a diameter within a range from about 1.0 mm to about 5.0 mm. Lens embodiments may include a peripheral portion comprised of a limited number of echelettes and a refractive portion. Central and peripheral echelettes can have a surface area that is between 1 and 7 mm2. For example, the echelettes may have a surface area that is 2.3 mm2. In some cases, a lens may include a peripheral portion which surrounds the echelettes. A lens may include a peripheral portion having an outer diameter within a range from about 4 mm to about 6 mm. In some cases, the peripheral portion will have an outer diameter within a range of about 1 mm to about 7 mm. For example, a lens may include a peripheral portion having an outer diameter of about 5 mm.
The echelettes may be characterized by a step height having a value within a range from about 0.5 μm and about 4 μm. According to some embodiments, a transition can be characterized by a step height having a value within a range of about 1.5 μm and 2.5 μm. According to some embodiments, a transition can be characterized by a step height having a value of about 1.7 μm. In other embodiments, the step height may have a value of about 2.0 μm.
Optionally, a diffractive profile can be characterized by a design wavelength, and a lens can include a transition characterized by a step height producing a phase shift between about 0.25 and about 1 times the design wavelength. In some cases, a diffractive profile can be characterized by a design wavelength, and the lens can include a transition characterized by a step height producing a phase shift between about 0.15 and about 2 times the design wavelength.
In some aspects, embodiments of the present invention encompass systems and methods involving an ophthalmic lens that include an anterior face with an anterior refractive profile and a posterior face with a posterior refractive profile, such that the faces are disposed about an optical axis, and a diffractive profile imposed on the anterior refractive profile or the posterior refractive profile, such that the diffractive profile includes an inner echelette and four or fewer outer echelettes. According to some embodiments, an inner echelette can be disposed within a central zone of the lens. In some cases, an inner echelette can be disposed within an annular ring surrounding a central zone of the lens. Optionally, an inner echelette and outer echelettes can be characterized by a parabolic curve. In some cases, an inner echelette and outer echelettes can be characterized by a constant phase shift. According to some embodiments, an ophthalmic lens may include an accommodating lens and/or a multifocal lens.
In one aspect, embodiments of the present invention encompass ophthalmic lenses, and systems and methods for their design and fabrication. Exemplary ophthalmic lenses may include a first surface and a second surface, where the first and second surfaces are disposed about an optical axis, an aspheric refractive profile imposed on the first or second surface, and a diffractive profile imposed on the first or second surface. The aspheric refractive profile can focus or direct light toward a far focus. The diffractive profile may include a central zone that distributes a first percentage of light toward a far focus and a second percentage of light toward an intermediate focus, and a peripheral zone, surrounding the central zone, that distributes a third percentage of light toward the far focus and a fourth percentage of light toward the intermediate focus. In some instances, the intermediate focus corresponds to an intraocular add power within a range between 1 Diopter and 2.5 Diopters. In some instances, the intermediate focus corresponds to an add power between 0.75 and 2 Diopters in the spectacle plane. In some instances, the intermediate focus corresponds to an intraocular add power of 1.75 Diopters. According to some embodiments, the far focus corresponds to a first diffractive order of the diffractive profile. In some cases, the far focus corresponds to a second diffractive order of the diffractive profile. In some cases, the far focus corresponds to a third diffractive order of the diffractive profile. In some cases, a difference between the intermediate focus and the far field focus corresponds to a power value within a range from about 1 Diopter to about 2.5 Diopters. Optionally, a difference between the intermediate focus and the far field focus may correspond to a power of about 1.75 Diopters. According to some embodiments, the central zone has an outer diameter within a range from about 1 mm to about 3 mm. According to some embodiments, the central zone has an outer diameter of about 2.2 mm. In some instances, the percentage of light distributed by the central zone toward the far focus is within a range between 41% and 63%, and the percentage of light distributed by the central zone toward the intermediate focus is within a range between 21% and 41%. In some instances, the percentage of light distributed by the central zone toward the far focus is 41% and the percentage of light distributed by the central zone toward the intermediate focus 41%. In some instances, the percentage of light distributed by the peripheral zone toward the far focus is within a range between 41% and 100% and the percentage of light distributed by the peripheral zone toward the intermediate focus is within a range from 0% to 41%. In some instances, the percentage of light distributed by the peripheral zone toward the far focus is 63% and the percentage of light distributed by the peripheral zone toward the intermediate focus is 21%. Optionally, the central zone may include one or more echelettes each having a step height, and the peripheral zone may include a plurality of echelettes each having a step height that is less than the step height of each central zone echelette. In some instances, the central zone includes two or more echelettes. Optionally, the central zone may include three or more echelettes. In some instances, the central zone may include two, three, four echelettes. According to some embodiments, the central zone includes at least one echelette having a step height of about 0.006 millimeters, and the peripheral zone includes at least one echelette having a step height of about 0.0055 millimeters. In some instances, the central zone includes at least one echelette having an optical path difference of 1.5 wavelengths, and the peripheral zone includes at least one echelette having an optical path difference of 1.366 wavelengths. In some instances, the central zone includes two echelettes each having a step height, and the peripheral zone includes seven echelettes each having a step height less than the step heights of the central zone echelettes. In some instances, the central zone includes an inner echelette having an outer diameter of 1.6 mm and an outer echelette having an outer diameter of 2.2 mm, where the inner and outer echelettes of the central zone each have a step height, and the peripheral zone includes seven echelettes each having a step height less than the step heights of the central zone echelettes. For an add power range of 1.0-2.5 Diopters, there may be one to five echelettes in the central zone and three to twenty four echelettes in the peripheral zone. For an add power range of 0.75-2.0 Diopters, there may be one to four echelettes in the central zone and three to nineteen echelettes in the peripheral zone. In some instances, the peripheral zone may have in the range of five to twelve echelettes. Optionally, the lens may provide an MTF at 50 c/mm of 24 at the intermediate focus and an MTF at 50 c/mm of 44 at the far focus.
In another aspect, embodiments of the present invention encompass ophthalmic lenses that include means for compensating for ocular spherical aberration, means for compensating for ocular chromatic aberration, and means for providing an extended depth of focus. In some instances, the means for providing an extended depth of focus includes a lens surface having a diffractive profile. In some instances, the means for providing an extended depth of focus includes a lens surface having a refractive profile. In some instances, the means for providing an extended depth of focus includes a lens surface having a diffractive and a refractive profile. In some instances, the means for providing an extended depth of focus includes a lens surface having a profile that is neither diffractive nor refractive.
In another aspect, embodiments of the present invention encompass ophthalmic lenses that include means for compensating for ocular spherical aberration, and means for compensating for ocular chromatic aberration. The means for compensating for ocular chromatic aberration and the means for compensating for ocular spherical aberration when combined can provide a far focus corresponding to a base power and an intermediate focus corresponding to an add power, and a difference between the base power and the add power can define an extended depth of focus for the lens. In some instances, the base power is within a range from 5 to 34 Diopters and the add power is within a range from 1 to 2.5 Diopters. In some instances, the means for compensating for ocular spherical aberration includes a lens surface having an aspherical profile. In some instances, the means for compensating for ocular chromatic aberration includes a lens surface having a diffractive profile. In some instances, the means for compensating for ocular chromatic aberration includes a lens material construction, the construction having a first material providing a first optical dispersion and a second material providing a second optical dispersion different from the first optical dispersion.
In still another aspect, embodiments of the present invention encompass ophthalmic lenses that include means for compensating for corneal spherical aberration, means for compensating for ocular chromatic aberration, and means for providing an extended depth of focus. In some instances, the means for providing an extended depth of focus includes a lens surface having a diffractive profile. In some instances, the means for providing an extended depth of focus includes a lens surface having a refractive profile. In some instances, the means for providing an extended depth of focus includes a lens surface having a diffractive and a refractive profile. In some instances, the means for providing an extended depth of focus includes a lens surface having a profile that is neither diffractive nor refractive.
In yet another aspect, embodiments of the present invention encompass ophthalmic lenses that include means for compensating for corneal spherical aberration, and means for compensating for ocular chromatic aberration. The means for compensating for ocular chromatic aberration and the means for compensating for ocular spherical aberration when combined can provide a modulation transfer function value at 50 cycles per millimeter of at least 10, for an intermediate focus, at 3 mm and 5 mm pupil diameters. In some cases, the means for compensating for corneal spherical aberration includes a lens surface having an aspherical profile. In some cases, the means for compensating for ocular chromatic aberration includes a lens surface having a diffractive profile. In some cases, the diffractive profile includes a central zone that distributes a first percentage of light toward a far focus and a second percentage of light toward the intermediate focus, and a peripheral zone, surrounding the central zone, that distributes a third percentage of light toward the far focus and a fourth percentage of light toward the intermediate focus. In some cases, the means for compensating for ocular chromatic aberration includes a lens material construction, the construction having a first material providing a first optical dispersion and a second material providing a second optical dispersion different from the first optical dispersion.
In yet another aspect, embodiments of the present invention encompass methods for generating an ophthalmic lens prescription for a patient. Exemplary methods may include inputting a patient parameter data profile specific for the patient, where the patient parameter data profile includes a patient spherical aberration parameter corresponding to a measured spherical aberration of the patient and a patient chromatic aberration parameter corresponding to a measured chromatic aberration of the patient. Methods may also include generating the ophthalmic lens prescription for the patient. The ophthalmic lens prescription can be configured to compensate for the measured patient spherical aberration and the measured patient chromatic aberration and to provide a far focus corresponding to a base power and an intermediate focus corresponding to an add power, where a difference between the base power and the add power defines an extended depth of focus for the ophthalmic lens. In some instances, the ophthalmic lens prescription may include a contact lens prescription, a phakic intraocular lens prescription, a pseudophakic intraocular lens prescription, or a corneal inlay prescription. In some instances, the patient spherical aberration parameter includes an ocular spherical aberration parameter. In some instances, the patient spherical aberration parameter includes a corneal spherical aberration parameter. In some instances, the patient chromatic aberration parameter includes an ocular chromatic aberration parameter. In some instances, the patient chromatic aberration parameter includes a corneal chromatic aberration parameter.
In still yet another aspect, embodiments of the present invention encompass methods for fabricating an ophthalmic lens prescription for a patient. Exemplary methods may include inputting an ophthalmic lens prescription for a patient, and fabricating the ophthalmic lens based on the prescription. In some cases, the ophthalmic lens is configured to compensate for a patient spherical aberration and a patient chromatic aberration, and the lens is configured to provide a far focus corresponding to a base power and an intermediate focus corresponding to an add power, where a difference between the base power and the add power defines an extended depth of focus for the ophthalmic lens. In some cases, the ophthalmic lens is a contact lens, a phakic intraocular lens, a pseudophakic intraocular lens, or a corneal inlay.
In another aspect, embodiments of the present invention encompass systems for generating an ophthalmic lens prescription for an eye of a patient. Exemplary systems may include an input that accepts a patient parameter data profile specific for the patient eye, where the patient parameter data profile includes a patient spherical aberration parameter corresponding to a measured spherical aberration of the patient eye and a patient chromatic aberration parameter corresponding to a measured chromatic aberration of the patient eye. Systems may also include a module having a tangible medium embodying machine-readable code that generates the ophthalmic lens prescription for the eye. The ophthalmic lens prescription can be configured to compensate for the measured spherical and chromatic aberrations and to provide a far focus corresponding to a base power and an intermediate focus corresponding to an add power, where a difference between the base power and the add power defines an extended depth of focus for the ophthalmic lens.
In one aspect, embodiments of the present invention encompass systems for fabricating an ophthalmic lens for an eye of a patient. Exemplary systems may include an input that accepts an ophthalmic lens prescription for the patient eye, where the ophthalmic lens prescription is configured to compensate for a measured patient spherical aberration and a measured patient chromatic aberration of the patient eye, and to provide a far focus corresponding to a base power and an intermediate focus corresponding to an add power. A difference between the base power and the add power can define an extended depth of focus for the ophthalmic lens prescription. Systems may also include a manufacturing assembly that fabricates the ophthalmic lens based on the lens prescription.
For further understanding of the nature and advantages of the present invention, reference should be made to the ensuing detailed description taken in conjunction with the accompanying drawings.
For illustration purposes, the profile geometries shown in certain aforementioned figures were not drawn exactly to scale. The heights of the profiles shown in some of the figures are generally on the order of about 0.1 μm to about 8.0 μm although the heights may vary depending on factors such as the amount of correction needed by the patient, the refractive index of the lens material and surrounding medium, and the desired distribution of light between wanted diffraction orders.
It is to be understood that the figures and descriptions of the present invention have been simplified to illustrate elements that are relevant for a clear understanding of the present invention, while eliminating, for the purpose of clarity and brevity, many other elements found in typical ophthalmic lenses, implantable optic apparatuses, systems and methods. Those of ordinary skill in the art may thus recognize that other elements and/or steps are desirable and/or required in implementing the present invention. However, because such elements and steps are well known in the art, and because they do not facilitate a better understanding of the present invention, a discussion of such elements and steps is not provided herein. The disclosure herein is directed to all such variations and modifications to the disclosed elements and methods known to those skilled in the art.
Embodiments of the present invention encompass systems and methods that provide improved image quality over an extended range of focal points or foci. Systems and methods disclosed herein can encompass various ophthalmic lenses such as, for example, contact lenses, intraocular lenses, spectacle lenses, and corneal inlays or onlays. Exemplary embodiments include ophthalmic lenses having an extended depth of focus, as compared to conventional monofocal lenses, and reduced dysphtopsia as compared to conventional multifocal ophthalmic lenses. In some cases, such techniques involve an IOL approach that includes a limited number of rings or echelettes, and typically involves an expanded depth of focus. Advantageously, such approaches can provide a patient with good distance vision, as well as good vision at intermediate and/or near distances without dysphotopsia.
Embodiments of the present invention generally provide improved lenses and imaging systems and may be incorporated into any system in which a lens with an extended depth of focus may be advantageous, such as camera/video lenses, including those used for surveillance or for surgical procedures, as well as for cameras in mobile phones or other related devices. Embodiments of the invention may find their most immediate use in the form of improved ophthalmic devices, systems, and methods. Exemplary embodiments of the present invention provide improved ophthalmic lenses (including, for example contact lenses, intraocular lenses (IOLs), corneal implants and the like) and associated methods for their design and use. Embodiments of the present invention may be used with monofocal diffractive or refractive lenses, bifocal diffractive or refractive lenses, and multifocal diffractive or refractive lenses, e.g. embodiments of the present invention could be added to the opposite surface of multifocal IOLs. In other words, an extended depth of focus feature may be added to, for example the opposite surface of a diffractive or refractive multifocal embodiment.
In addition, an extended depth of focus feature may be added to, for example, a toric IOL, an IOL that modifies ocular spherical and/or chromatic aberration, and/or an accommodating IOL. In general, an extended depth of focus feature may be added to an IOL that modifies ocular aberrations.
Reading is often done in bright light conditions in which the pupil is small. In contrast, night-time driving is done in low light conditions in which the pupil is large. Embodiments of the present invention encompass lenses that relatively emphasize intermediate or near vision for small pupil sizes, while also relatively emphasizing far vision for large pupil sizes. In some such ophthalmic lenses, a greater proportion of light energy may be transmitted to the far focus from a peripheral portion of the lens to accommodate for low light, far viewing conditions such as night time driving, with the near or intermediate viewing receiving relatively more light energy from a central portion of the diffractive profile—for reading or computer work for example and/or to provide depth of focus and intermediate or near viewing under low light reading conditions as in for example reading restaurant menus.
Each major face of lens 11, including the anterior (front) surface and posterior (back) surface, generally has a refractive profile, e.g. biconvex, plano-convex, plano-concave, meniscus, etc. The two surfaces together, in relation to the properties of the surrounding aqueous humor, cornea, and other optical components of the overall optical system, define the effects of the lens 11 on the imaging performance by eye E. Conventional, monofocal IOLs have a refractive power based on the refractive index of the material from which the lens is made, and also on the curvature or shape of the front and rear surfaces or faces of the lens.
In a young, healthy eye contraction and relaxation of ciliary muscles 17 surrounding the capsular bag 14 contribute to accommodation of the eye, the process by which the eye increases optical power to maintain focus on objects as they move closer. As a person ages, the degree of accommodation decreases and presbyopia, the diminished ability to focus on near objects, often results. A patient may therefore conventionally use corrective optics having two optical powers, one for near vision and one for far vision, as provided by multifocal IOL 11.
Multifocal lenses may optionally also make special use of the refractive properties of the lens. Such lenses generally include different powers in different regions of the lens so as to mitigate the effects of presbyopia. For example, as shown in
Rather than relying entirely on the refractive properties of the lens, multifocal diffractive IOLs or contact lenses can also have a diffractive power, as illustrated by the IOL 18 shown in
The diffractive profile of a diffractive multifocal lens directs incoming light into a number of diffraction orders. As light 13 enters from the front of the eye, the multifocal lens 18 directs light 13 to form a far field focus 15a on retina 16 for viewing distant objects and a near field focus 15b for viewing objects close to the eye. Depending on the distance from the source of light 13, the focus on retina 16 may be the near field focus 15b instead. Typically, far field focus 15a is associated with 0th diffractive order and near field focus 15b is associated with the 1st diffractive order, although other orders may be used as well.
Multifocal ophthalmic lens 18 typically distributes the majority of light energy into the two viewing orders, often with the goal of splitting imaging light energy about evenly (50%:50%), one viewing order corresponding to far vision and one viewing order corresponding to near vision, although typically, some fraction goes to non-viewing orders.
In some embodiments, corrective optics may be provided by phakic IOLs, which can be used to treat patients while leaving the natural lens in place. Phakic IOLs may be angle supported, iris supported, or sulcus supported. The phakic IOL can be placed over the natural crystalline lens or piggy-backed over another IOL. It is also envisioned that the present invention may be applied to inlays, onlays, accommodating IOLs, spectacles, and even laser vision correction.
When fitted onto the eye of a subject or patient, the optical axis of lens 20 is generally aligned with the optical axis of eye E. The curvature of lens 20 gives lens 20 an anterior refractive profile and a posterior refractive profile. Although a diffractive profile may also be imposed on either anterior face 21 and posterior face 22 or both,
As shown in
The adjacent echelette(s) in the outer portion (not shown) are detailed below. Profile 200 includes an inner portion 210 or single ring, a step or transition 220, and an outer portion 230. The outer portion 230 extends beyond that disclosed in
The inner portion or echelette 210 includes a center 210a and a peripheral edge 210b. At center or central section 210a of inner portion 210 where radial distance is zero, the sag (d) of inner portion is between the sag (d) of the diffractive base curve 240 and the sag (d) of the peripheral curve 260 at 1.03 μm from the peripheral curve 260, corresponding with a phase delay of 0.25 lambda (see table 2). At peripheral edge 210b, the sag (d) of inner portion 210 is substantially equivalent to the sag (d) of diffractive base curve 240 at 13.8 μm. The value of sag (d) between radial distance zero and radial distance at the peripheral edge 210b at 0.61 mm, gradually and smoothly changes from 1.03 μm (at r=0) to the value of the base curve 240 (at r=0.61 mm) which is 13.8 μm. This change occurs in a parabolic fashion. As shown here, inner portion can present a parabolic shape, for example as described in Equation 4a of Cohen, Applied Optics, 31:19, pp. 3750-3754 (1992), incorporated herein by reference.
At the peripheral edge 210b where the radial distance (r) is 0.61 mm, the value of sag (d) steps or changes from the value of diffractive base curve 240 to the value of peripheral curve 260. Where radial distance (r) corresponds to transition 220, sag (d) of inner portion is equivalent to the value of the diffractive base curve 240. Relatedly, the displacement of the profile approaches that of the diffractive base curve as the radial distance increases from a value of zero to a value of about 0.61 mm. The step height is 2.05 μm resulting in a phase delay of 0.5.
The outer portion 230 includes an inner or central edge 230a and a peripheral edge (not shown). At inner edge 230a, the sag (d) of outer portion is substantially equivalent to the sag (d) of peripheral curve 260. At peripheral edge, the sag (d) of outer portion remains substantially equivalent to the sag (d) of peripheral curve 260. As detailed below, a limited number of echelettes may be located between inner edge 230a and peripheral edge.
As shown in
According to some embodiments, light comes from below, in the direction indicated by arrow A, and only hits the echelettes 930 of the profile. According to some embodiments, in theoretical terms light does not hit the vertical connection of the optical zones, and hence the profile can be said to have no transition zone. According to some embodiments, in practice when one attempts to produce such a profile, for instance by lathe cutting, it may be difficult to reproduce the sharp corner (e.g. at where the optical zone connects with the adjacent optical zone) and hence the corner may be rounded to some extent due to the finite chisel radius. Such rounding may have a negligible effect on the optical performance. According to related embodiments, transition zone 931, which can be referred to as the transition from the echelette to the adjacent zone or zones, can be shaped in a specific way, so as to optimize the optical performance, for example to minimize scatter from a sharp transition.
The profile design can be characterized in terms of a set of parameters. For example, the limited echelette profile can be described as having a central echelette with a diameter and surface area, an adjacent echelette(s) with the same surface area, and an associated step height at each transition resulting in a phase delay. The central echelette may have a diameter within a range from about 1 mm to about 5 mm. For example, the central echelette may have a diameter of about 1.5 mm. Central echelette may have a surface area that is between 1 and 7 mm2. For example, the central echelette may have a surface area that is 2.3 mm2. The peripheral echelette(s) may have a surface area equal to the central echelette. In particular, Table 1 discloses the dimensions of the radius and diameter of the central echelette, along with the surface area of the central and peripheral echelettes.
The step height or profile height can determine the phase delay or phase shifting profile. A greater step height can correspond to a greater phase shift. According to some embodiments, a lens can include a transition characterized by a step height producing a phase shift between about 0.25 and about 1 times the design wavelength. In some cases, a diffractive profile can be characterized by a design wavelength, and the lens can include a transition characterized by a step height producing a phase shift between about 0.15 and about 2 times the design wavelength. According to some embodiments the lens may include a transition characterized by a step height producing a phase shift of about 0.5. In other embodiments, the lens may include a transition characterized by a step height of about 0.4.
Table 2 provides dimensions of various samples disclosing the relationship between phase delay (in wavelengths) and step height (in μm), as valid for an example IOL material.
Although the above preferred embodiments disclose lenses with echelettes that have equal step heights, preferred embodiments herein also include lenses with echelettes with varying step heights as detailed in, for example,
The size of the human pupil varies with illumination. In bright light the pupil is small, and in dim or low light conditions the pupil is large. In addition, the size of the human pupil varies with accommodative effort. Without accommodative effort, the pupil is larger than with accommodative effort. Hence, for a smaller pupil, it may be desirable to provide a design that places a relative emphasis on intermediate or near vision. For a larger pupil, it may be desirable to provide a design that places a relative emphasis on far vision.
In typical reading or near vision conditions where the light is bright, the size of the pupil is small, e.g. between about 1 mm and 2 mm in diameter, and the eye has a large depth of focus (for example from a pinhole effect), almost irrespective of the optics of the IOL. When the size of the pupil is large, e.g. larger than about 4-5 mm in diameter, the situation generally applies to low light conditions, and is often associated with distance vision for which the power of the IOL is typically established. Therefore, many patients would benefit most from an IOL that enhances the depth of focus in order to view at intermediate distances. An IOL having a central echelette with limited adjacent echelettes may effectively increase the depth of focus for intermediate pupil sizes, while maintaining the general increased depth of focus of small pupil sizes, and also maintaining an emphasis on far vision for large pupil sizes.
At the same time, since the limited echelettes and the remaining surface area of the optic or remaining lens portion (“non-echelette”) have unequal surface areas for almost all pupil sizes, there is an incomplete split between the foci. The condition of dysphotopsia (e.g. halos) that is present for multifocal lenses is observed to be dominated by separation of two foci and pupil size effects. Accordingly, pursuant to exemplary embodiments of the present invention, the lens may include only a limited number of echelettes, so that light separation between distinct foci is not complete, as compared to standard diffractive multifocal IOLs. Since the split of light is incomplete, the separation of foci is incomplete. The incomplete separation of foci contributes to the extended depth of focus and the attenuation of dysphotopsia (e.g. halos).
In an exemplary embodiment, the limited echelette design has an optical performance that depends on the pupil size. For very small pupils, where the pupil is smaller than the size of the central and adjacent echelette(s), the echelette will act as a refractive lens, having a very large depth of focus due to the pinhole effect. For medium and higher pupil sizes, where the pupil covers the central echelette and the adjacent echelette, the lens will act as a diffractive/refractive lens, directing the light to several foci. For higher pupil sizes, more light is being directed to the lower order foci. The size of the central and adjacent echelette(s) influences the pupil dependence of the lens. As such, the size of the central and adjacent echelette(s) can be chosen, depending on the pupil sizes of a specific patient. For example, the pupil sizes of a patient may be measured in bright light, in dim light, during far vision and during near vision, and in the different combinations of light level and accommodative effort. These different pupil sizes, which may be defined as pupil dynamics, can be used as input parameters for an optimal design of the limited echelette design.
For example, if a patient has a pupil diameter during near vision (e.g. viewing target at close distance, with high accommodative effort) smaller than 2 mm, having this pupil dimension with both bright and dim light, then the size of the central and adjacent echelette(s) may be selected to be smaller than 2 mm (e.g. outer diameter of the adjacent echelette of
Embodiments of the present invention may be combined with a multifocal lens design, and with that extend the depth of focus of each focus of the multifocal lens. Similarly, embodiments of the present invention may be combined with an accommodating lens design, by which the range of accommodation of the accommodating lens can be extended. In addition, embodiments of the present invention may be combined with lenses correcting ocular aberrations, like toric lenses, aspherical lenses, lenses correcting chromatic aberrations, and the like.
Embodiments of the present invention may be combined with a lens design correcting chromatic aberrations. In one embodiment, the phase delay of the echelettes in the preceding examples is increased by a discrete multiple of wavelengths, in order to correct for chromatic aberration. For example, if a phase delay of 0.5 was used, corresponding to a step height of 2.05 μm, an alternative embodiment would have a phase delay of 1.5, corresponding to a step height of 6.15 μm. This embodiment directs the first order diffraction to the far focus, and the second order diffraction establishes the depth of focus at the intermediate and near range.
Embodiments of the present invention encompass ophthalmic lenses having an aspheric anterior surface and a diffractive posterior surface, which provide extended depth of focus and compensate for natural chromatic and spherical aberration produced by the eye. Although many of the examples provided herein describe a diffractive profile disposed at the posterior of an ophthalmic lens, it is understood that a diffractive profile can also be disposed at the anterior lens surface, or in some cases at both anterior and posterior surfaces, with similar results. Similarly, although many of the examples provided herein describe an aspherical anterior surface, it is understood that an aspherical profile can also be disposed at the posterior lens surface, or in some cases at both anterior and posterior surface, with similar results. Exemplary ophthalmic lenses include contact lenses, phakic lenses, pseudophakic lenses, corneal inlays, and the like.
The far field focus 730 may correspond to a base power of the lens, and the intermediate focus 740 may correspond to an add power of the lens. In some cases, the far focus 730 corresponds to a first diffractive order of the diffractive profile. Optionally, the far focus 730 may correspond to a second diffractive order of the diffractive profile. Similarly, the far focus may correspond to a third diffractive order of the diffractive profile. Often, the intermediate focus 740 corresponds to a diffractive order (e.g. 2nd) of the diffractive profile that is higher than the diffractive order (e.g. 1st) corresponding to the far focus 730. The base power value for the lens may vary depending on the type of lens. Similarly, the add power for the lens may vary depending on the type of lens. For an intraocular lens, the base power value may be within a range between 5 to 34 Diopters, or even wider. For a contact lens, the base power value may be within a range between −10 to +5 Diopters or even wider. For an exemplary intraocular lens, the base power can be 20 Diopters, and the add power can be 1.75 Diopters. It is understood that other similar add powers corresponding to the intermediate focus can be used. Such an add power is substantially lower than many current multifocal intraocular lenses, which often provide an add power in the range from 3.0 to 4.0 Diopters. For an exemplary contact lens, the add power may be about 1.3 Diopters.
As shown here, the diffractive profile includes a central diffractive zone 750 and an outer or peripheral diffractive zone 760. The central zone 750 encompasses two inner echelettes, or rings, having diameters of 1.6 mm and 2.2 respectively. The central zone 750 operates to direct 41% of incident or incoming light to far field focus 730, and 41% of incident or incoming light to intermediate focus 740. In this sense, the central zone 750 can be said to provide a light distribution between far and intermediate of 50:50%. That is, the percentage of light directed to each of the far and intermediate focus points is 50% of the sum of the light distributed between the far focus and intermediate focus (i.e. 41/(41+41)=50%). It is understood that other diffractive profile central zones providing different light distributions may be used.
The peripheral zone 760 operates to direct 63% of incident or incoming light to far field focus 730, and 21% of incident or incoming light to intermediate focus 740. In this sense, the peripheral zone 760 can be said to provide a light distribution between far and intermediate of 75:25%. That is, the percentage of light directed to the far focus is 75% of the sum of the light distributed to the far focus and intermediate focus (i.e. 63/(63+21)=75%), and the percentage of light directed to the intermediate focus is 25% of the sum of the light distributed between the far focus and intermediate focus (i.e. 21/(63+21)=25%). It is understood that other diffractive profile peripheral zones providing different light distributions may be used.
In this way, the diffractive optical element includes multiple zones, where each zone acts to concentrate or direct incident light in specific directions according to specific diffractive orders. In some instances, about 16% to 18% of the light is lost to spurious diffractive orders. According to some embodiments, the zeroth order is not used for vision treatment purposes.
The lens 700 provides an extended depth of focus to an eye of a patient. For example, the lens can bring faraway objects and objects at intermediate distances into focus for the patient simultaneously. When the lens is administered to the patient, the patient will not perceive two distinct focal images (e.g. two images corresponding to far and intermediate focus, respectively), but rather will experience a true extended depth of focus, with a constant or gradual decrease in visual quality when objects become closer to the eye.
By combining an aspheric anterior surface that corrects for spherical aberration, and posterior diffractive surface that corrects for chromatic aberration, lenses as disclosed herein provide excellent contrast properties in addition to an extended depth of focus. For example, the diffractive surface combined with the aspheric surface can correct or reduce chromatic aberration produced by the eye at various foci.
It is understood that in some embodiments, correction or treatment of chromatic aberration can also be achieved by providing a lens containing a combination of two materials having different dispersion characteristics, for example as described by Bradley et al. “Achromatizing the human eye” Optom. Vis. Sci. 68, 608-16 (1991), the content of which is incorporated herein by reference. For example, lens design can use pairings of materials that have the same refractive index at some intermediate wavelength, e.g., 588 nm, but different amounts of chromatic dispersion to create lenses with zero power at 588 nm but with opposite power at wavelengths above and below 588 nm. An alternative embodiment of the present invention involves the correction of chromatic aberration using two materials having different dispersion characteristics, in combination with an aspherical refractive surface and diffractive rings to extend the depth of focus.
Embodiments of the present invention encompass ophthalmic lenses and lens prescriptions, as well as systems and methods for producing such lenses and prescriptions. Exemplary lenses include lens surfaces, disposed about an optical axis, which provide aspheric and diffractive profiles. The aspheric profile can direct light toward a far focus, and the diffractive profile includes (i) a central zone that distributes a first percentage of light toward a diffractive order at the far focus and a second percentage of light toward another diffractive order at an intermediate focus disposed anterior to the far focus, and (ii) a peripheral zone, surrounding the central zone, that distributes a first percentage of light toward the diffractive order at the far focus and a second percentage of light toward the other diffractive order at the intermediate focus. In some instances, the aspheric profile is provided by an anterior face of the lens. In some cases, the diffractive profile is provided by the posterior face of the lens.
As noted elsewhere herein, different diffractive zones can provide different light distributions to different focus points (e.g. between far and intermediate). Table 3 provides an illustrative example.
As noted elsewhere herein, the intermediate focus corresponds to the add power. Hence, lens designs such as those represented by Table 3 are different than currently known lens designs which the entirety of the lens directs 50% of the light toward the add power. Such known lens designs may not sufficiently correct or treat chromatic aberration in the far focus. Further, such known lens designs have an add power that is substantially larger than that provided by embodiments of the present invention. In some instances of the present invention, exemplary lens designs include a peripheral zone which directs 25% of the distributed light toward the add power. What is more, because lens designs according to embodiments of the present invention may provide a diffractive profile across the entire lens or a substantial portion thereof, such lenses are different than currently known lens designs which do not provide a diffractive profile or diffractive effect at large pupil sizes.
In some instances, a diffractive profile includes 9 rings on a 5 mm diameter optic surface. The diffractive profile can include two central rings each having a step height that is larger than the step heights of the other seven peripheral rings. The diffractive profile can provide a monofocal diffractive surface that at least partially corrects or compensates for natural chromatic aberration produced by the patient's eye. The aspheric anterior surface of the ophthalmic lens can operate to correct or treat spherical aberration of the eye. In some instances, lens system and methods embodiments of the present invention may incorporate features of lenses and treatments disclosed in U.S. Pat. No. 6,830,332, which discusses lenses having both aspheric anterior surfaces and diffractive posterior surfaces. In some cases, lens designs may also incorporate diffractive surfaces, for example which direct 63% of the total light to the far focus and 21% to a near or intermediate focus. In some instances, a diffractive surface can provide an add power of 1.75 D, with a central 2.2 mm diameter zone that directs 41% of the total light to far focus and 41% to intermediate focus, surrounded by an outer zone which directs 63% of the total light to the far focus and 21% to the intermediate focus. Exemplary diffractive surfaces can be pupil independent, have an add power of 1.75 Diopters, and provide a central zone light distribution between the far focus and the intermediate focus of 50%:50% and a peripheral zone light distribution between the far focus and the intermediate focus of 75%:25%. In optical terms, the diffractive profile provides a plurality of foci.
In some embodiments, the diffractive profile 800 can be represented as the incorporation of two diffractive echelettes 802 and 810 on top of a base ophthalmic lens configuration.
A base ophthalmic lens configuration may include a diffractive surface profile such as that described in U.S. Pat. No. 6,830,332, incorporated herein by reference. For example, the base lens configuration may include an achromatic design having a profile height that is equal to one wavelength, as discussed at column 4, lines 42-43 of the '332 patent. Embodiments of the present invention encompass designs that include extended depth of focus (EDOF) step heights that are placed on top of such an achromatic design.
In some instances, a base ophthalmic lens configuration may incorporate a pupil independent diffractive profile over the entire optic. Hence, the lens can continue to provide excellent intermediate vision properties as the pupil widens in low light conditions. This pupil independent diffractive profile may have the same ring structure (add power) as the two echelettes. As a result, the two echelettes show up as two central echelettes having higher profile height (step height) on an otherwise constant-height diffractive profile.
In some instances, each echelette or ring has a step height or profile height that is larger than one wavelength. For example, a wavelength can be 550 nm, as that described in U.S. Pat. No. 6,830,332, incorporated herein by reference. Accordingly, the diffractive profile can operate to distribute incident or incoming light substantially or predominately to the first and second diffractive orders, for example to far focus 730 and intermediate focus 740 of
In some instances, a diffractive profile of an ophthalmic lens produces chromatic aberration in light directed to the first and second diffractive orders that is opposite in sign to the chromatic aberration produced by the natural eye (e.g. a natural phakic or aphakic eye into which an intra-ocular lens is eventually placed). Hence, the diffractive profile can operate to at least partially correct, offset, or otherwise treat the eye's natural chromatic aberration. For example, optical parts of a patient's aphakic eye 900 may introduce chromatic aberration as depicted in
As depicted here,
By introducing an ophthalmic lens 910 as depicted in
In some instances, light rays at the periphery of the patient eye (e.g. cornea) may be over-refracted, thus producing a region of defocused light that decreases image quality, for example due to spherical aberration. In some cases, the cornea, optionally in combination with other optical parts of the eye, can produce spherical aberration. Hence, spherical aberration may in various instances be referred to as corneal spherical aberration or ocular spherical aberration. An aspheric surface of the ophthalmic lens can compensate for such spherical aberration, by reducing the amount by which the peripheral light rays are refracted. For example, as shown in
According to some embodiments, an ophthalmic lens 900 can operate to treat or correct chromatic aberration over a range of foci, or over an extended depth of focus. For example, an ophthalmic lens can provide a partial correction or treatment of chromatic aberration in the far focus (e.g. focus 730 of
For example, let the nth diffractive order be associated with the far focus of the ophthalmic lens, and the jth diffractive order be associated with the intermediate focus (focus range) of the ophthalmic lens. The difference between the orders is j−n. For an extended depth of focus lens, the difference in lens power (e.g. in unit of Diopters) between the intermediate and the far vision denotes the range of extended depth of focus.
Relatedly, let the chromatic aberration of the ophthalmic lens in the nth diffractive order, or far focus, be characterized as LCAf with the following equation:
LCAf=LCAr+n*LCAd
Here, LCAr refers to the longitudinal chromatic aberration of the refractive base lens and LCAd refers to the longitudinal chromatic aberration of the diffractive profile. It is noted that the above equation includes a “+” sign, however the value of LCAd in the equation is negative.
Similarly, the chromatic aberration of the diffractive focus for the jth diffractive order, or intermediate vision, can be characterized as LCA, with the following equation:
LCAi=LCAr+j*LCAd.
For designs having correction of ocular chromatic aberration, LCAf and LCAi should have negative values.
Let the chromatic aberration of the aphakic eye be LCAae. Correction of the ocular chromatic aberration, without over-correction is obtained if:
−LCAf≤LCAae
and
−LCAi≤LCAae
Or:
n≤(LCAae+LCAr)/(−LCAd)
j≤(LCAae+LCAr)/(−LCAd)
For example, with a diffractive profile having positive diffractive orders, LCAae=2 D, LCAr=1.5 D and LCAd=−1.75 D. Full chromatic aberration is obtained in the intermediate vision for the diffraction order of j=(2+1.5)/1.75=2. In such a case, the first diffractive order leaves the eye with a LCA of (2+1.5−1*1.75)=1.75 D, and giving a reduction of LCA by 1.75 D of the pseudophakic eye (e.g. artificial lens implanted), and 0.25 D reduction of the aphakic eye (e.g. natural lens removed).
Table 4 provides step height, diameter, optical path difference (OPD in wavelength λ) and light distribution values for an exemplary diffractive profile, according to embodiments of the present invention.
According to some embodiments, the step heights are configured so that the lens generally functions using the 1st and 2nd diffractive orders. The specific step heights used may depend on the refractive index of the material present in the lens, and/or the wavelength considered. Typically, each step height creates a difference in optical path length. Hence, assuming that the refractive index of the aqueous of the eye is 1.336, and considering an ophthalmic lens material having a refractive index 1.47, an approximately four micron step height introduces an optical path difference of one wavelength. In some instances, embodiments of the present invention encompass lens designs having step height values greater than four microns. In some instances, embodiments of the present invention encompass lens designs having step height values within a range between four and 8 microns. In some instances, embodiments of the present invention encompass lens designs having echelette step heights that introduce optical path difference values that are greater than one.
As indicated in Table 4, an exemplary ophthalmic lens can include a central zone having two echelettes that operate to direct light between far and intermediate foci at a 50:50 relative ratio for an EDOF effect at small and medium pupil sizes. The further peripheral echelettes operate in combination to direct light between far and intermediate foci at a 75:25 relative ratio, which can maintain an EDOF effect for larger pupil sizes.
As shown here, the peak 1010 at intermediate focus (about 1.3 Diopters in the spectacle plane) can change in the horizontal position, by changing the diffractive add power of the ophthalmic lens. For example, adjusting the echelette diameters of the central and outer diffractive zones (e.g. as shown in
Relatedly, the peak 1020 at far focus (0 Diopters) can change in the vertical position, by changing the light distribution of the ophthalmic lens. For example, adjusting the step heights of the central and outer diffractive zones (e.g. as shown in
Hence, according to some embodiments, variations in lens step heights can operate to change light distribution properties of the lens, and with that, the vertical positions of 1010 and 1020. Further, variations in ring diameters can operate to change the add power properties of the lens, and with that, the horizontal positions of 1010.
The result of these variations are shown in
Additional details regarding the use of modulation transfer function (MTF) to evaluate the performance of a visual system (e.g. ophthalmic lens and/or other optical parts of the eye) are described in U.S. Patent Publication No. 2009/0210054, which is incorporated herein by reference.
Model eye data demonstrating that a single ring ophthalmic lens design can provide an extended depth of field effect is provide in previously incorporated U.S. Patent Application No. 61/288,255 filed Dec. 18, 2009.
The images of
For example, with the Xring 311 design, the USAF image at −1.50 Diopter defocus is sharper than the image at −1.0 Diopter defocus. The magnitude of this feature is much smaller than what is observed for a multifocal lens. That is, the sharpness difference between −1.50 Diopters and −1.00 Diopter is smaller for the Xring design and larger for the multifocal design. Moreover, the overall sharpness throughout this range is higher for the Xring design as compared to the multifocal design. Therefore, it can be expected that in clinical terms, functional vision at the entire intermediate range is comparable to that at best focus, with a visual acuity of around 20/20. For example, for Xring 311, the intermediate range is estimated to run from 0 to at least −1.75 Diopters.
Various techniques for evaluating the depth of focus in a visual system (e.g. ophthalmic lens and/or other optical parts of the eye) are described in U.S. Patent Publication No. 2009/0210054, which is incorporated herein by reference.
Ophthalmic lens embodiments of the present invention can be configured to compensate for various aberrations produced by a patient eye, such as spherical and chromatic aberration, which may derive from the cornea and/or other optical parts of the patient eye. Hence, methods of designing and/or fabricating such lenses may involve obtaining or using data related to aberrations of the patient eye. Any of a variety of aberrometers, including wavefront measurement systems, may be used to obtain such aberration data. The components of an exemplary wavefront measurement system for measuring the eye and aberrations may comprise elements of a WaveScan® system, available from AMO MANUFACTURING USA, LLC, Milpitas, Cali. One embodiment includes a WaveScan system with a deformable mirror. An alternate embodiment of a wavefront measuring system is described in U.S. Pat. No. 6,271,915, the full disclosure of which is incorporated herein by reference. It is appreciated that any wavefront aberrometer could be employed for use with embodiments of the present invention. Relatedly, embodiments of the present invention encompass the implementation of any of a variety of optical instruments provided by AMO W
In some cases, embodiments of the present invention encompass systems, kits, and computer program products for manufacturing or fabricating ophthalmic lenses as disclosed herein. Ophthalmic lenses can be fabricated using laser ablation processes, and/or may incorporate standard techniques for the manufacture of intraocular lenses, aspects of which are described in U.S. Pat. Nos. 4,856,234, 5,322,649, and 5,888,122, as well as U.S. Patent Publication No. 2002/0082690. The content of each of these patent publications is incorporated herein by reference. Relatedly, in some instances manufacturing or fabrication processes may include aspects of molding, polishing, measuring of the power, quality control, modeling, and the like.
Each of the calculations, operations, methods, and processes described herein may be performed using a computer or other processor having hardware, software, and/or firmware. The various method steps may be performed by modules, and the modules may comprise any of a wide variety of digital and/or analog data processing hardware and/or software arranged to perform the method steps described herein. The modules optionally comprising data processing hardware adapted to perform one or more of these steps by having appropriate machine programming code associated therewith, the modules for two or more steps (or portions of two or more steps) being integrated into a single processor board or separated into different processor boards in any of a wide variety of integrated and/or distributed processing architectures. These methods and systems will often employ a tangible media embodying machine-readable code with instructions for performing the method steps described above. Suitable tangible media may comprise a memory (including a volatile memory and/or a non-volatile memory), a storage media (such as a magnetic recording on a floppy disk, a hard disk, a tape, or the like; on an optical memory such as a CD, a CD-R/W, a CD-ROM, a DVD, or the like; or any other digital or analog storage media), or the like.
The embodiments described above, including accompanying drawings, figures, functions and tables, are for illustrative purposes to explain aspects of the present invention. Hence, while the exemplary embodiments have been described in some detail, by way of example and for clarity of understanding, those of skill in the art will recognize that a variety of modification, adaptations, and changes may be employed. Hence, the scope of the claims should not be limited to the description of the preferred versions contained herein.
The present application is a continuation application of and claims priority to U.S. application Ser. No. 15/149,574, filed on May 9, 2016, which is a divisional application of and claims priority to U.S. application Ser. No. 14/014,701, filed on Aug. 30, 2013, now U.S. Pat. No. 9,335,563, which claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 61/695,806, filed on Aug. 31, 2012. This application is related to U.S. patent application Ser. No. 12/971,607 filed Dec. 17, 2010, now U.S. Pat. No. 8,480,228, which issued on Jul. 9, 2013, which claims the benefit of priority to U.S. Provisional Patent Application No. 61/288,255 filed Dec. 18, 2009. Further, this application is related to the following applications which were filed Dec. 17, 2010: Single Microstructure Lens, Systems and Methods, U.S. patent application Ser. No. 12/971,506, now U.S. Pat. No. 8,430,508, which issued on Apr. 30, 2013; Ophthalmic Lens, Systems And Methods With Angular Varying Phase Delay, U.S. patent application Ser. No. 12/971,889, now U.S. Pat. No. 8,444,267, which issued on May 21, 2013; and Ophthalmic Lens, Systems And Methods Having At Least One Rotationally Asymmetric Diffractive Structure, U.S. Patent Application No. 61/424,433. This application is also related to the following U.S. Patent Application No. 61/047,699 and Ser. No. 12/109,251, now U.S. Pat. No. 7,871,162, which issued on Jan. 18, 2011, both filed on Apr. 24, 2008; Ser. No. 12/429,155 filed on Apr. 23, 2009, now U.S. Pat. No. 8,231,219, which issued on Jul. 31, 2012; Ser. No. 12/372,573 filed on Feb. 17, 2009, now abandoned; Ser. No. 12/197,249 filed on Aug. 23, 2008; Ser. No. 12/120,201 filed on Apr. 13, 2008, and Ser. No. 12/771,550 filed on Apr. 30, 2010. What is more, this application is related to U.S. Pat. Nos. 6,830,332 and 7,896,916. The entire disclosure of each of the above filings is incorporated herein by reference for all purposes. Full Paris Convention priority is hereby expressly reserved.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3367734 | Karl et al. | Feb 1968 | A |
| 3722986 | Tagnon | Mar 1973 | A |
| 4210391 | Cohen et al. | Jul 1980 | A |
| 4340283 | Cohen et al. | Jul 1982 | A |
| 4460275 | Spriggs | Jul 1984 | A |
| 4504892 | Zulfilar | Mar 1985 | A |
| 4504982 | Burk | Mar 1985 | A |
| 4580883 | Shinohara | Apr 1986 | A |
| 4606626 | Shinohara | Aug 1986 | A |
| 4637697 | Freeman | Jan 1987 | A |
| 4640593 | Shinohara | Feb 1987 | A |
| 4641934 | Freeman | Feb 1987 | A |
| 4642112 | Freeman | Feb 1987 | A |
| 4655565 | Freeman | Apr 1987 | A |
| 4710193 | Volk | Dec 1987 | A |
| 4762408 | Shinohara | Aug 1988 | A |
| 4778462 | Grendahl | Oct 1988 | A |
| 4795462 | Grendahl | Jan 1989 | A |
| 4798608 | Grendahl | Jan 1989 | A |
| 4798609 | Grendahl | Jan 1989 | A |
| 4856234 | Goins | Aug 1989 | A |
| 4856889 | Guilino et al. | Aug 1989 | A |
| 4881804 | Cohen | Nov 1989 | A |
| 4881805 | Cohen | Nov 1989 | A |
| 4898461 | Portney | Feb 1990 | A |
| 4932970 | Portney | Jun 1990 | A |
| 4936666 | Futhey | Jun 1990 | A |
| 4957506 | Mercier | Sep 1990 | A |
| 4978211 | Cornu et al. | Dec 1990 | A |
| 4995714 | Cohen | Feb 1991 | A |
| 4995715 | Cohen | Feb 1991 | A |
| 5016977 | Baude et al. | May 1991 | A |
| 5017000 | Cohen | May 1991 | A |
| 5019098 | Mercier | May 1991 | A |
| 5050981 | Roffman | Sep 1991 | A |
| 5054905 | Cohen | Oct 1991 | A |
| 5056908 | Cohen | Oct 1991 | A |
| 5061058 | Guilino et al. | Oct 1991 | A |
| 5066301 | Wiley | Nov 1991 | A |
| 5076684 | Simpson et al. | Dec 1991 | A |
| 5089023 | Swanson | Feb 1992 | A |
| 5089024 | Christie et al. | Feb 1992 | A |
| 5096285 | Silberman | Mar 1992 | A |
| 5100226 | Freeman | Mar 1992 | A |
| 5104212 | Taboury et al. | Apr 1992 | A |
| 5112351 | Christie et al. | May 1992 | A |
| 5114220 | Baude et al. | May 1992 | A |
| 5116111 | Simpson et al. | May 1992 | A |
| 5117306 | Cohen | May 1992 | A |
| 5120120 | Cohen | Jun 1992 | A |
| 5121979 | Cohen | Jun 1992 | A |
| 5121980 | Cohen | Jun 1992 | A |
| 5129718 | Futhey et al. | Jul 1992 | A |
| 5144483 | Cohen | Sep 1992 | A |
| 5148205 | Guilino et al. | Sep 1992 | A |
| 5161057 | Johnson | Nov 1992 | A |
| 5173723 | Volk et al. | Dec 1992 | A |
| 5178636 | Silberman | Jan 1993 | A |
| 5191366 | Kashiwagi | Mar 1993 | A |
| 5220359 | Roffman | Jun 1993 | A |
| 5225858 | Portney | Jul 1993 | A |
| 5229797 | Futhey et al. | Jul 1993 | A |
| 5236970 | Christ et al. | Aug 1993 | A |
| 5257132 | Ceglio et al. | Oct 1993 | A |
| 5260727 | Oksman et al. | Nov 1993 | A |
| 5322649 | Rheinish et al. | Jun 1994 | A |
| 5344447 | Swanson | Sep 1994 | A |
| 5349394 | Freeman et al. | Sep 1994 | A |
| 5349471 | Morris et al. | Sep 1994 | A |
| 5381190 | Rehse et al. | Jan 1995 | A |
| 5384606 | Koch et al. | Jan 1995 | A |
| 5408281 | Zhang | Apr 1995 | A |
| 5443506 | Garabet | Aug 1995 | A |
| 5443507 | Jacobi | Aug 1995 | A |
| 5444106 | Zhou et al. | Aug 1995 | A |
| 5446508 | Kitchen | Aug 1995 | A |
| 5448312 | Roffman et al. | Sep 1995 | A |
| 5485228 | Roffman et al. | Jan 1996 | A |
| 5581405 | Meyers et al. | Dec 1996 | A |
| 5589982 | Faklis et al. | Dec 1996 | A |
| 5629800 | Hamblen | May 1997 | A |
| 5652638 | Roffman et al. | Jul 1997 | A |
| 5674284 | Chang et al. | Oct 1997 | A |
| 5682223 | Menezes et al. | Oct 1997 | A |
| 5683457 | Gupta et al. | Nov 1997 | A |
| 5684560 | Roffman et al. | Nov 1997 | A |
| 5684595 | Kato et al. | Nov 1997 | A |
| 5699142 | Lee et al. | Dec 1997 | A |
| 5715031 | Roffman et al. | Feb 1998 | A |
| 5715091 | Meyers | Feb 1998 | A |
| 5724258 | Roffman | Mar 1998 | A |
| 5728156 | Gupta et al. | Mar 1998 | A |
| 5748282 | Freeman | May 1998 | A |
| 5760871 | Kosoburd et al. | Jun 1998 | A |
| 5777719 | Williams et al. | Jul 1998 | A |
| 5796462 | Roffman et al. | Aug 1998 | A |
| 5800532 | Lieberman | Sep 1998 | A |
| 5805260 | Roffman et al. | Sep 1998 | A |
| 5822091 | Baker | Oct 1998 | A |
| 5838496 | Maruyama et al. | Nov 1998 | A |
| 5847802 | Menezes et al. | Dec 1998 | A |
| 5888122 | Gupta et al. | Mar 1999 | A |
| 5895422 | Hauber | Apr 1999 | A |
| 5895610 | Chang et al. | Apr 1999 | A |
| 5929969 | Roffman | Jul 1999 | A |
| 5968094 | Werblin et al. | Oct 1999 | A |
| 5968095 | Norrby | Oct 1999 | A |
| 5982543 | Fiala | Nov 1999 | A |
| 6007747 | Blake et al. | Dec 1999 | A |
| 6019472 | Koester et al. | Feb 2000 | A |
| 6050687 | Bille et al. | Apr 2000 | A |
| 6070980 | Obara et al. | Jun 2000 | A |
| 6082856 | Dunn et al. | Jul 2000 | A |
| 6086204 | Magnante | Jul 2000 | A |
| 6089711 | Blankenbecler et al. | Jul 2000 | A |
| 6095651 | Williams et al. | Aug 2000 | A |
| 6120148 | Fiala et al. | Sep 2000 | A |
| 6126283 | Wen et al. | Oct 2000 | A |
| 6126286 | Portney | Oct 2000 | A |
| 6139145 | Israel | Oct 2000 | A |
| 6142625 | Sawano et al. | Nov 2000 | A |
| 6145987 | Baude et al. | Nov 2000 | A |
| 6154323 | Kamo | Nov 2000 | A |
| 6199986 | Williams et al. | Mar 2001 | B1 |
| 6210005 | Portney | Apr 2001 | B1 |
| 6215096 | Von Wallfeld et al. | Apr 2001 | B1 |
| 6224211 | Gordon | May 2001 | B1 |
| 6231603 | Lang et al. | May 2001 | B1 |
| 6270220 | Keren | Aug 2001 | B1 |
| 6271915 | Frey et al. | Aug 2001 | B1 |
| 6325510 | Golub et al. | Dec 2001 | B1 |
| 6338559 | Williams et al. | Jan 2002 | B1 |
| 6353503 | Spitzer et al. | Mar 2002 | B1 |
| 6413276 | Werblin | Jul 2002 | B1 |
| 6429972 | Ota et al. | Aug 2002 | B1 |
| 6439720 | Graves et al. | Aug 2002 | B1 |
| 6457826 | Lett | Oct 2002 | B1 |
| 6462874 | Soskind | Oct 2002 | B1 |
| 6464355 | Gil | Oct 2002 | B1 |
| 6474814 | Griffin | Nov 2002 | B1 |
| 6488708 | Sarfarazi | Dec 2002 | B2 |
| 6491721 | Freeman et al. | Dec 2002 | B2 |
| 6497483 | Frey et al. | Dec 2002 | B2 |
| 6511180 | Guirao et al. | Jan 2003 | B2 |
| 6520638 | Roffman et al. | Feb 2003 | B1 |
| 6527389 | Portney | Mar 2003 | B2 |
| 6533416 | Fermigier et al. | Mar 2003 | B1 |
| 6536899 | Fiala | Mar 2003 | B1 |
| 6537317 | Steinert et al. | Mar 2003 | B1 |
| 6547391 | Ross, III et al. | Apr 2003 | B2 |
| 6547822 | Lang | Apr 2003 | B1 |
| 6554425 | Roffman et al. | Apr 2003 | B1 |
| 6554859 | Lang et al. | Apr 2003 | B1 |
| 6557992 | Dwyer et al. | May 2003 | B1 |
| 6576012 | Lang | Jun 2003 | B2 |
| 6582076 | Roffman et al. | Jun 2003 | B1 |
| 6585375 | Donitzky et al. | Jul 2003 | B2 |
| 6609673 | Johnson | Aug 2003 | B1 |
| 6609793 | Norrby et al. | Aug 2003 | B2 |
| 6616275 | Dick et al. | Sep 2003 | B1 |
| 6655802 | Zimmermann et al. | Dec 2003 | B2 |
| 6685315 | De Carle | Feb 2004 | B1 |
| 6705729 | Piers et al. | Mar 2004 | B2 |
| 6709103 | Roffman et al. | Mar 2004 | B1 |
| 6755524 | Rubinstein et al. | Jun 2004 | B2 |
| 6791754 | Ogawa | Sep 2004 | B2 |
| 6802605 | Cox et al. | Oct 2004 | B2 |
| 6808262 | Chapoy et al. | Oct 2004 | B2 |
| 6818158 | Pham et al. | Nov 2004 | B2 |
| 6827444 | Williams et al. | Dec 2004 | B2 |
| 6830332 | Piers et al. | Dec 2004 | B2 |
| 6835204 | Stork et al. | Dec 2004 | B1 |
| 6846326 | Zadno-Azizi et al. | Jan 2005 | B2 |
| 6848790 | Dick et al. | Feb 2005 | B1 |
| 6851803 | Wooley et al. | Feb 2005 | B2 |
| 6884261 | Zadno-Azizi et al. | Apr 2005 | B2 |
| 6923539 | Simpson et al. | Aug 2005 | B2 |
| 6923540 | Ye et al. | Aug 2005 | B2 |
| 6951391 | Morris et al. | Oct 2005 | B2 |
| 6957891 | Fiala | Oct 2005 | B2 |
| 6972032 | Aharoni et al. | Dec 2005 | B2 |
| 6986578 | Jones | Jan 2006 | B2 |
| 7025456 | Morris et al. | Apr 2006 | B2 |
| 7036931 | Lindacher et al. | May 2006 | B2 |
| 7048759 | Bogaert et al. | May 2006 | B2 |
| 7048760 | Cumming | May 2006 | B2 |
| 7061693 | Zalevsky | Jun 2006 | B2 |
| 7073906 | Portney | Jul 2006 | B1 |
| 7093938 | Morris et al. | Aug 2006 | B2 |
| 7111938 | Andino et al. | Sep 2006 | B2 |
| 7137702 | Piers et al. | Nov 2006 | B2 |
| 7156516 | Morris et al. | Jan 2007 | B2 |
| 7159983 | Menezes et al. | Jan 2007 | B2 |
| 7188949 | Bandhauer et al. | Mar 2007 | B2 |
| 7198640 | Nguyen | Apr 2007 | B2 |
| 7217375 | Lai | May 2007 | B2 |
| 7221513 | Cho et al. | May 2007 | B2 |
| 7232218 | Morris et al. | Jun 2007 | B2 |
| 7287852 | Fiala | Oct 2007 | B2 |
| 7293873 | Dai et al. | Nov 2007 | B2 |
| 7365917 | Zalevsky | Apr 2008 | B2 |
| 7377640 | Piers et al. | May 2008 | B2 |
| 7377641 | Piers et al. | May 2008 | B2 |
| 7441894 | Zhang et al. | Oct 2008 | B2 |
| 7455404 | Bandhauer et al. | Nov 2008 | B2 |
| 7475986 | Dai et al. | Jan 2009 | B2 |
| 7481532 | Hong et al. | Jan 2009 | B2 |
| 7543937 | Piers et al. | Jun 2009 | B2 |
| 7572007 | Simpson | Aug 2009 | B2 |
| 7604350 | Dursteler Lopez et al. | Oct 2009 | B2 |
| 7615073 | Deacon et al. | Nov 2009 | B2 |
| 7654667 | Blum et al. | Feb 2010 | B2 |
| 7670371 | Piers et al. | Mar 2010 | B2 |
| 7677725 | Piers et al. | Mar 2010 | B2 |
| 7717558 | Hong et al. | May 2010 | B2 |
| 7753521 | Wooley et al. | Jul 2010 | B2 |
| 7871162 | Weeber | Jan 2011 | B2 |
| 7883207 | Iyer et al. | Feb 2011 | B2 |
| 7896916 | Piers et al. | Mar 2011 | B2 |
| 7922326 | Bandhauer et al. | Apr 2011 | B2 |
| 7984990 | Bandhauer et al. | Jul 2011 | B2 |
| 7998198 | Angelopoulos et al. | Aug 2011 | B2 |
| 8128222 | Portney | Mar 2012 | B2 |
| 8157374 | Bandhauer et al. | Apr 2012 | B2 |
| 8192022 | Zalevsky | Jun 2012 | B2 |
| 8197063 | Iyer et al. | Jun 2012 | B2 |
| 8216307 | Schaper, Jr. | Jul 2012 | B2 |
| 8231219 | Weeber | Jul 2012 | B2 |
| 8231673 | Sacharoff et al. | Jul 2012 | B2 |
| 8235525 | Lesage et al. | Aug 2012 | B2 |
| 8240850 | Apter et al. | Aug 2012 | B2 |
| 8241354 | Hong et al. | Aug 2012 | B2 |
| 8262728 | Zhang et al. | Sep 2012 | B2 |
| 8292953 | Weeber et al. | Oct 2012 | B2 |
| 8382281 | Weeber | Feb 2013 | B2 |
| 8388137 | Dreher et al. | Mar 2013 | B2 |
| 8430508 | Weeber | Apr 2013 | B2 |
| 8444267 | Weeber et al. | May 2013 | B2 |
| 8480228 | Weeber | Jul 2013 | B2 |
| 8500805 | Kobayashi et al. | Aug 2013 | B2 |
| 8506075 | Bandhauer et al. | Aug 2013 | B2 |
| 8529623 | Piers et al. | Sep 2013 | B2 |
| 8556416 | Lawu | Oct 2013 | B2 |
| 8556417 | Das et al. | Oct 2013 | B2 |
| 8573775 | Weeber | Nov 2013 | B2 |
| 8619362 | Portney | Dec 2013 | B2 |
| 8636796 | Houbrechts et al. | Jan 2014 | B2 |
| 8652205 | Hong et al. | Feb 2014 | B2 |
| 8678583 | Cohen | Mar 2014 | B2 |
| 8709079 | Zhang et al. | Apr 2014 | B2 |
| 8734511 | Weeber et al. | May 2014 | B2 |
| 8740978 | Weeber et al. | Jun 2014 | B2 |
| 8747466 | Weeber et al. | Jun 2014 | B2 |
| 8755117 | Kobayashi et al. | Jun 2014 | B2 |
| 8771348 | Zhao | Jul 2014 | B2 |
| 8827446 | Iyer et al. | Sep 2014 | B2 |
| 8906089 | Piers et al. | Dec 2014 | B2 |
| 9069185 | Zhao | Jun 2015 | B2 |
| 9078745 | Zhang et al. | Jul 2015 | B2 |
| 9122074 | Piers et al. | Sep 2015 | B2 |
| 9164201 | Fermigier et al. | Oct 2015 | B2 |
| 9223148 | Fiala et al. | Dec 2015 | B2 |
| 9304329 | Zhao | Apr 2016 | B2 |
| 9310624 | Argal et al. | Apr 2016 | B2 |
| 9320594 | Schwiegerling | Apr 2016 | B2 |
| 9329309 | Van Heugten | May 2016 | B2 |
| 9335563 | Weeber | May 2016 | B2 |
| 9335564 | Choi et al. | May 2016 | B2 |
| 9370416 | Argal et al. | Jun 2016 | B2 |
| 9518864 | Grossinger et al. | Dec 2016 | B2 |
| 9563070 | Ando et al. | Feb 2017 | B2 |
| 9622856 | Weeber et al. | Apr 2017 | B2 |
| 9869580 | Grossinger et al. | Jan 2018 | B2 |
| 9925041 | Gerlach et al. | Mar 2018 | B2 |
| 20010018612 | Carson et al. | Aug 2001 | A1 |
| 20020082690 | Sarbadhikari | Jun 2002 | A1 |
| 20020093701 | Zhang et al. | Jul 2002 | A1 |
| 20020105617 | Norrby et al. | Aug 2002 | A1 |
| 20020118337 | Perrott et al. | Aug 2002 | A1 |
| 20020122153 | Piers et al. | Sep 2002 | A1 |
| 20030014107 | Reynard | Jan 2003 | A1 |
| 20030063254 | Piers et al. | Apr 2003 | A1 |
| 20030076478 | Cox | Apr 2003 | A1 |
| 20030169491 | Bender et al. | Sep 2003 | A1 |
| 20030171808 | Phillips | Sep 2003 | A1 |
| 20040021824 | Ye et al. | Feb 2004 | A1 |
| 20040080710 | Wooley et al. | Apr 2004 | A1 |
| 20040085515 | Roffman et al. | May 2004 | A1 |
| 20040088050 | Norrby et al. | May 2004 | A1 |
| 20040106992 | Lang et al. | Jun 2004 | A1 |
| 20040111153 | Woods et al. | Jun 2004 | A1 |
| 20040138746 | Aharoni et al. | Jul 2004 | A1 |
| 20040150789 | Jones | Aug 2004 | A1 |
| 20040156014 | Piers et al. | Aug 2004 | A1 |
| 20040169820 | Dai et al. | Sep 2004 | A1 |
| 20040189981 | Ross et al. | Sep 2004 | A1 |
| 20040230299 | Simpson et al. | Nov 2004 | A1 |
| 20040246440 | Andino et al. | Dec 2004 | A1 |
| 20040252274 | Morris et al. | Dec 2004 | A1 |
| 20050057720 | Morris et al. | Mar 2005 | A1 |
| 20050096226 | Stock et al. | May 2005 | A1 |
| 20050099589 | Ishak | May 2005 | A1 |
| 20050128432 | Altmann | Jun 2005 | A1 |
| 20050203619 | Altmann | Sep 2005 | A1 |
| 20050259222 | Kelch et al. | Nov 2005 | A1 |
| 20050264757 | Morris et al. | Dec 2005 | A1 |
| 20050267575 | Nguyen et al. | Dec 2005 | A1 |
| 20060004446 | Aharoni et al. | Jan 2006 | A1 |
| 20060009816 | Fang et al. | Jan 2006 | A1 |
| 20060030938 | Altmann | Feb 2006 | A1 |
| 20060034003 | Zalevsky | Feb 2006 | A1 |
| 20060055883 | Morris et al. | Mar 2006 | A1 |
| 20060066808 | Blum et al. | Mar 2006 | A1 |
| 20060098162 | Bandhauer | May 2006 | A1 |
| 20060098163 | Bandhauer | May 2006 | A1 |
| 20060109421 | Ye et al. | May 2006 | A1 |
| 20060116763 | Simpson | Jun 2006 | A1 |
| 20060116764 | Simpson | Jun 2006 | A1 |
| 20060139570 | Blum et al. | Jun 2006 | A1 |
| 20060176572 | Fiala | Aug 2006 | A1 |
| 20060238702 | Glick et al. | Oct 2006 | A1 |
| 20060244904 | Hong et al. | Nov 2006 | A1 |
| 20060244905 | Piers et al. | Nov 2006 | A1 |
| 20070002444 | Piers et al. | Jan 2007 | A1 |
| 20070052920 | Stewart et al. | Mar 2007 | A1 |
| 20070129803 | Cumming et al. | Jun 2007 | A1 |
| 20070171362 | Simpson et al. | Jul 2007 | A1 |
| 20070182924 | Hong et al. | Aug 2007 | A1 |
| 20070236769 | Zalevsky | Oct 2007 | A1 |
| 20070258143 | Portney | Nov 2007 | A1 |
| 20070268451 | Raghuprasad | Nov 2007 | A1 |
| 20070282438 | Hong et al. | Dec 2007 | A1 |
| 20080030677 | Simpson | Feb 2008 | A1 |
| 20080147185 | Hong et al. | Jun 2008 | A1 |
| 20080161913 | Brady et al. | Jul 2008 | A1 |
| 20080161914 | Brady et al. | Jul 2008 | A1 |
| 20080269891 | Hong et al. | Oct 2008 | A1 |
| 20080273169 | Blum et al. | Nov 2008 | A1 |
| 20080300679 | Altmann | Dec 2008 | A1 |
| 20090062911 | Bogaert | Mar 2009 | A1 |
| 20090088840 | Simpson et al. | Apr 2009 | A1 |
| 20090164008 | Hong et al. | Jun 2009 | A1 |
| 20090187242 | Weeber et al. | Jul 2009 | A1 |
| 20090210054 | Weeber et al. | Aug 2009 | A1 |
| 20090234448 | Weeber et al. | Sep 2009 | A1 |
| 20090240328 | Treushnikov et al. | Sep 2009 | A1 |
| 20090268155 | Weeber | Oct 2009 | A1 |
| 20090295295 | Shannon et al. | Dec 2009 | A1 |
| 20090323020 | Zhao et al. | Dec 2009 | A1 |
| 20100014049 | Bandhauer et al. | Jan 2010 | A1 |
| 20100016961 | Hong et al. | Jan 2010 | A1 |
| 20100057202 | Bogaert | Mar 2010 | A1 |
| 20100066973 | Portney | Mar 2010 | A1 |
| 20100087921 | Simpson | Apr 2010 | A1 |
| 20100097569 | Weeber et al. | Apr 2010 | A1 |
| 20100100177 | Zhao | Apr 2010 | A1 |
| 20100100178 | Weeber et al. | Apr 2010 | A1 |
| 20100131060 | Simpson et al. | May 2010 | A1 |
| 20100161048 | Schaper, Jr. | Jun 2010 | A1 |
| 20100161051 | Hong | Jun 2010 | A1 |
| 20100274233 | Dick et al. | Oct 2010 | A1 |
| 20100281021 | Weeber et al. | Nov 2010 | A1 |
| 20100312336 | Hong et al. | Dec 2010 | A1 |
| 20100312337 | Zhang et al. | Dec 2010 | A1 |
| 20100321635 | Apter et al. | Dec 2010 | A1 |
| 20110022170 | Simpson et al. | Jan 2011 | A1 |
| 20110098811 | Hong et al. | Apr 2011 | A1 |
| 20110109874 | Piers et al. | May 2011 | A1 |
| 20110125261 | Portney | May 2011 | A1 |
| 20110149236 | Weeber | Jun 2011 | A1 |
| 20110166652 | Bogaert et al. | Jul 2011 | A1 |
| 20110267693 | Kobayashi et al. | Nov 2011 | A1 |
| 20110270596 | Weeber | Nov 2011 | A1 |
| 20110292335 | Schwiegerling | Dec 2011 | A1 |
| 20110313522 | Hayes | Dec 2011 | A1 |
| 20110313523 | Hayes | Dec 2011 | A1 |
| 20110313525 | Cumming | Dec 2011 | A1 |
| 20110317124 | Weeber et al. | Dec 2011 | A1 |
| 20110317126 | Weeber | Dec 2011 | A1 |
| 20120029630 | Piers et al. | Feb 2012 | A1 |
| 20120059464 | Zhao | Mar 2012 | A1 |
| 20120140166 | Zhao | Jun 2012 | A1 |
| 20120143326 | Canovas Vidal et al. | Jun 2012 | A1 |
| 20120154740 | Bradley et al. | Jun 2012 | A1 |
| 20120165932 | Argal | Jun 2012 | A1 |
| 20120170121 | Okada et al. | Jul 2012 | A1 |
| 20120283825 | Houbrechts et al. | Nov 2012 | A1 |
| 20120320335 | Weeber et al. | Dec 2012 | A1 |
| 20120323321 | Simonov et al. | Dec 2012 | A1 |
| 20130035760 | Portney | Feb 2013 | A1 |
| 20130046381 | Zalevsky et al. | Feb 2013 | A1 |
| 20130060330 | Weeber et al. | Mar 2013 | A1 |
| 20130090730 | Weeber et al. | Apr 2013 | A1 |
| 20130107202 | Liang | May 2013 | A1 |
| 20130201445 | Das et al. | Aug 2013 | A1 |
| 20150022775 | Ando et al. | Jan 2015 | A1 |
| 20150029460 | Bradley et al. | Jan 2015 | A1 |
| 20150094807 | Piers et al. | Apr 2015 | A1 |
| 20150359625 | Argal et al. | Dec 2015 | A1 |
| 20160216535 | Zhao et al. | Jul 2016 | A1 |
| 20160220350 | Gerlach | Aug 2016 | A1 |
| 20160220352 | Choi et al. | Aug 2016 | A1 |
| 20160320633 | Weeber et al. | Nov 2016 | A1 |
| 20160334640 | De Juan, Jr. et al. | Nov 2016 | A1 |
| 20160341978 | Schwiegerling | Nov 2016 | A1 |
| 20170172088 | May | Jun 2017 | A1 |
| 20170209259 | Choi et al. | Jul 2017 | A1 |
| 20170216020 | Weeber et al. | Aug 2017 | A1 |
| 20170219846 | Ando | Aug 2017 | A1 |
| 20170227789 | Ando et al. | Aug 2017 | A1 |
| 20170239038 | Choi et al. | Aug 2017 | A1 |
| 20170245985 | Canovas Vidal et al. | Aug 2017 | A1 |
| 20170245986 | Canovas Vidal et al. | Aug 2017 | A1 |
| 20170245987 | Canovas Vidal et al. | Aug 2017 | A1 |
| 20170252151 | Mackool | Sep 2017 | A1 |
| 20180092739 | Pagnoulle et al. | Apr 2018 | A1 |
| 20180132996 | Tiwari et al. | May 2018 | A1 |
| 20180147050 | Choi et al. | May 2018 | A1 |
| 20180147052 | Hong et al. | May 2018 | A1 |
| 20180373060 | Knox et al. | Dec 2018 | A1 |
| 20190224000 | Choi et al. | Jul 2019 | A1 |
| 20190254810 | Tiwari et al. | Aug 2019 | A1 |
| 20190307557 | De Carvalho et al. | Oct 2019 | A1 |
| 20190314148 | Liu | Oct 2019 | A1 |
| 20200038172 | Hussain et al. | Feb 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 2005230194 | Dec 2010 | AU |
| 2501217 | Apr 2004 | CA |
| 2507659 | Jun 2004 | CA |
| 2590085 | Jun 2006 | CA |
| 1951340 | Apr 2007 | CN |
| 101181171 | Apr 2011 | CN |
| 102665611 | Sep 2012 | CN |
| 69715830 | Aug 2003 | DE |
| 335731 | Oct 1989 | EP |
| 342895 | Nov 1989 | EP |
| 0343067 | Nov 1989 | EP |
| 355230 | Feb 1990 | EP |
| 0369561 | May 1990 | EP |
| 375291 | Jun 1990 | EP |
| 412751 | Feb 1991 | EP |
| 0457553 | Nov 1991 | EP |
| 470811 | Feb 1992 | EP |
| 0537643 | Apr 1993 | EP |
| 605841 | Jul 1994 | EP |
| 0316162 | Oct 1995 | EP |
| 355230 | Oct 1995 | EP |
| 681198 | Nov 1995 | EP |
| 0537643 | Mar 1997 | EP |
| 0926531 | Jun 1999 | EP |
| 949529 | Oct 1999 | EP |
| 1376203 | Jan 2004 | EP |
| 1424049 | Jun 2004 | EP |
| 1862148 | Dec 2007 | EP |
| 1310267 | Jan 2008 | EP |
| 1891912 | Feb 2008 | EP |
| 2043558 | Apr 2009 | EP |
| 2045648 | Apr 2009 | EP |
| 1402308 | May 2009 | EP |
| 1424049 | Jun 2009 | EP |
| 2103279 | Sep 2009 | EP |
| 2113226 | Nov 2009 | EP |
| 2365379 | Sep 2011 | EP |
| 2377493 | Oct 2011 | EP |
| 2378319 | Oct 2011 | EP |
| 2290411 | May 2012 | EP |
| 2363097 | Sep 2012 | EP |
| 2527908 | Nov 2012 | EP |
| 2812882 | Dec 2014 | EP |
| 2813881 | Dec 2014 | EP |
| 2349093 | Oct 2015 | EP |
| 3150170 | Dec 2017 | EP |
| 1215851 | Feb 1990 | IT |
| 1154119 | Jun 1989 | JP |
| 2028615 | Jan 1990 | JP |
| 2079815 | Mar 1990 | JP |
| 2137814 | May 1990 | JP |
| 2249631 | Oct 1990 | JP |
| 3011315 | Jan 1991 | JP |
| 2000511299 | Aug 2000 | JP |
| 2003532157 | Oct 2003 | JP |
| 2010158315 | Jul 2010 | JP |
| 2013101323 | May 2013 | JP |
| 101154066 | Jun 2012 | KR |
| 2011154235 | Jul 2013 | RU |
| 2011154238 | Jul 2013 | RU |
| 9002963 | Mar 1990 | WO |
| 9222264 | Dec 1992 | WO |
| 9303409 | Feb 1993 | WO |
| 9413225 | Jun 1994 | WO |
| 9417435 | Aug 1994 | WO |
| 9724639 | Jul 1997 | WO |
| 9744689 | Nov 1997 | WO |
| 9831299 | Jul 1998 | WO |
| 9907309 | Feb 1999 | WO |
| 9923526 | May 1999 | WO |
| 0019906 | Apr 2000 | WO |
| 0076426 | Dec 2000 | WO |
| 0121061 | Mar 2001 | WO |
| 0163344 | Aug 2001 | WO |
| 0182839 | Nov 2001 | WO |
| 0189424 | Nov 2001 | WO |
| 0221194 | Mar 2002 | WO |
| 0234158 | May 2002 | WO |
| 02084381 | Oct 2002 | WO |
| 02088830 | Nov 2002 | WO |
| 03009053 | Jan 2003 | WO |
| 2004013680 | Feb 2004 | WO |
| 2004034129 | Apr 2004 | WO |
| 2004049979 | Jun 2004 | WO |
| 2004090611 | Oct 2004 | WO |
| 2004096014 | Nov 2004 | WO |
| 2004113959 | Dec 2004 | WO |
| 05019906 | Mar 2005 | WO |
| 06025726 | Mar 2006 | WO |
| 2006047698 | May 2006 | WO |
| 06060477 | Jun 2006 | WO |
| 2006060480 | Jun 2006 | WO |
| 2006067255 | Jun 2006 | WO |
| 2007092948 | Aug 2007 | WO |
| 2007133384 | Nov 2007 | WO |
| 2008045847 | Apr 2008 | WO |
| 2008150982 | Dec 2008 | WO |
| 2009017403 | Feb 2009 | WO |
| 2009027438 | Mar 2009 | WO |
| 2009043985 | Apr 2009 | WO |
| 2009058755 | May 2009 | WO |
| 2009076670 | Jun 2009 | WO |
| 2009130610 | Oct 2009 | WO |
| 2009148454 | Dec 2009 | WO |
| 2010046356 | Apr 2010 | WO |
| 2010054255 | May 2010 | WO |
| 2010059764 | May 2010 | WO |
| 2010079528 | Jul 2010 | WO |
| 2010093975 | Aug 2010 | WO |
| 2010100523 | Sep 2010 | WO |
| 2010104530 | Sep 2010 | WO |
| 2010144315 | Dec 2010 | WO |
| 2011024125 | Mar 2011 | WO |
| 2011055228 | May 2011 | WO |
| 2011075641 | Jun 2011 | WO |
| 2011075668 | Jun 2011 | WO |
| 2012004746 | Jan 2012 | WO |
| 2012031211 | Mar 2012 | WO |
| 2012070313 | May 2012 | WO |
| 2012078763 | Jun 2012 | WO |
| 2012085917 | Jun 2012 | WO |
| 2012122411 | Sep 2012 | WO |
| 2012140389 | Oct 2012 | WO |
| 2013018379 | Feb 2013 | WO |
| 2013028992 | Feb 2013 | WO |
| 2013093916 | Jun 2013 | WO |
| 2013114209 | Aug 2013 | WO |
| 2013116133 | Aug 2013 | WO |
| 2013118177 | Aug 2013 | WO |
| 2013118499 | Aug 2013 | WO |
| 2014008343 | Jan 2014 | WO |
| 2014033543 | Mar 2014 | WO |
| 2014091528 | Jun 2014 | WO |
| 2014111831 | Jul 2014 | WO |
| 2014189049 | Nov 2014 | WO |
| 2017137841 | Aug 2017 | WO |
| 2017149403 | Sep 2017 | WO |
| 2019130030 | Jul 2019 | WO |
| Entry |
|---|
| Schwiegerling et al., “Representation of videokeratoscopic height data with Zemike polynomials,” Journal of the Optical Society of America, 1995, 12 (10), 2105-2113. |
| Seitz B., et al, “Corneal Topography,” Current Opinion in Ophthalmolgy, 1997, vol. 8 (4), pp. 8-24. |
| Smith G. et al., “The spherical aberration of the crystalline lens of the human eye,” Vision Res., 2001, 41 (2), 235-243. |
| Smith Kinney, “Sensitivity of the eye to spectral radiation at scotopic and mesopic intensity levels,” Journal of the Optical Society of America, 1955, 45 (7), 507-514. |
| Thibos L. N. et al., “The chromatic eye: a new reduced-eye model of ocular chromatic aberration in humans,” Applied Optics, 1992, 31 (19), 3594-3600. |
| Thibos L. N. et al., “Theork and measurement of ocular chromatic aberration,” Vision Res, 1988, 30 (1), 33-49. |
| Townsley, “New Knowledge of the corneal contour,” Contacto, 1970, pp. 38-43. |
| Verriest G., “The Spectral Curve of Relative Luminous Efficiency in Different Age Groups of Aphakic Eyes,” Mod Probl Ophthalmol., 1974, 13, 314-317. |
| Wang J.Y., et al, “Wave-Front Interpretation With Zemike Polynomials,” Applied Optics, 1980, vol. 19 (9), pp. 1510-1518. |
| Albert D.M., “(Book Review) Intraocular Lenses: Evolution, Designs, Complications, and Pathology, by David Apple et al.,” Archieves of Opthalmology, 1990, vol. 108, pp. 650. |
| Alvarez S. L. et al., “Spectral threshold: measurement and clinical applications,” British Journal of Ophthalmology, 1983, 67, 504-507. |
| Apple D.J., et al., Eds., “Intraocular Lenses: Evolution, Designs, Complications and Pathology,” in: New Concepts in Intraocular Lens Implantation, Williams & Wilkins publisher, Jan. 1989, vol. 22 (36), pp. 205-221. |
| Apple D.J., et al., Eds., “Intraocular Lenses: Evolution, Designs, Complications and Pathology,” in: New Concepts in Intraocular Lens Implantation, Williams & Wilkins publisher, Jan. 1989, vol. 36 (1), pp. 21-36. |
| Artal P., et al., “Contributions of the Cornea and the Lens to the Aberrations of the Human Eye,” Optics Letters, 1998, vol. 23 (21), pp. 1713-1715. |
| Atchinson D.A., “Design of Aspheric Intraocular Lens,” Ophthamic & Physiological Optics, 1991, vol. 11 (2), pp. 137-146. |
| Atchinson D.A., et al., “Optical Design of Intraocular Lenses. II. Off-Axis performance,” Optometry & Vision Science, 1989, vol. 66 (9), pp. 579-590. |
| Atchinson D.A., et al., “Third-Order Aberrations of Pseudophakic Eyes,” Ophthalmic and Physiological Optics , 1989, vol. 9, pp. 205-211. |
| Atchinson D.A., “Optical Design of Intraocular Lenses. I. On-Axis Performance,” American Academy of Optometry, 1989, vol. 66 (8), pp. 492-506. |
| Atchinson D.A., “Optical design of intraocular lenses III. On-Axis Performance in the Presence of Lens Displacement,” American Academy of Optometry, 1989, vol. 66 (10), pp. 671-681. |
| Atchinson, “Refractive errors induced by displacement of intraocular lenses within the pseudophakic eye,” Optometry & Vision Science, 1989, 66 (3), 146-152. |
| Bonnet R., et al, “New Method of Topographical Ophthalmometry-Its Theoretical and Clinical Applications,” American Journal of Optometry, 1962, vol. 39 (5), pp. 227-251. |
| Bradley A. et al., “Achromatizing the Human Eye” Optometry & Vision Science, 1991, vol. 68 (8), pp. 608-616. |
| Buralli D.A., et al, “Optical Performance of Holographic Kinoforms,” Applied Optics, Mar. 1989, vol. 28 (5), pp. 976-983. |
| Cohen A.L., “Diffractive Bifocal Lens Design,” Optometry and Vision Science, Jun. 1993, vol. 70 (6), pp. 461-468. |
| Cohen A.L., “Practical Design of a Bifocal Hologram Contact Lens or Intraocular Lens,” Applied Optics, Jul. 1, 1992, vol. 31 (19), pp. 3750-3754. |
| Dwyer W. O. et al., “Racial Differences in Color Vision: Do They Exist”, American Journal of Optometry & Physiological Optics, 1975, 52, 224-229. |
| El Hage S.G., et al., “Contribution of the Crystalline Lens to the Spherical Aberration of the Eye,” 1973, vol. 63 (2), pp. 205-211. |
| European Search Report for Application No. 12181569, dated Sep. 18, 2012, 7 pages. |
| Futhey J.A., “Diffractive Bifocal Intraocular Lens,” SPIE, 1989, vol. 1052, pp. 142-148. |
| Geun Y., et al., “Visual Performance after Correcting the Monchromatic and Chromatic Aberrations of the Eye,” Journal of the Optical Society of America, 2002, vol. 19 (2), pp. 266-275. |
| Glasser A. et al., “Presbyopia and the optical changes in the human crystalline lens with age,” Vision Res, 1998, 38 (2), 209-229. |
| Greivenkamp J.E., et al., “Visual Acuity Modeling Using Optical Raytracing of Schematic Eyes,” American Journal of Ophthalmology, 1995, vol. 120 (2), pp. 227-240. |
| Griswold Scott et al., “Scotopic Spectral Sensitivity of Phakic and Aphakic Observers Extending into the Near Ultraviolet,” Vision res, 1992, 32 (9), 1739-1743. |
| Guirao A., et al., “Corneal Wave Aberration from Videokeratography: Accuracy and Limitations of the Procedure,” Journal of the Optical Society of America, 2000, vol. 17 (6), pp. 955-965. |
| International Preliminary Examination Report for PCT/EP03/13683, dated Sep. 16, 2004, 2 pages. |
| International Preliminary Report on Patentability and Written Opinion for Application No. PCT/US2005/038820, dated May 1, 2007, 6 pages. |
| International Preliminary Report on Patentability and Written Opinion for Application No. PCT/US2005/38821, dated May 1, 2007, 6 pages. |
| International Search Report and Written Opinion for Application No. PCT/IB2013/002390 dated May 12, 2014, 24 pages. |
| International Search Report for Application No. PCT/EP03/13683, dated Mar. 29, 2004, 6 pages. |
| International Search Report for Application No. PCT/US2005/38820, dated Mar. 3, 2006, 3 pages. |
| International Search Report for Application No. PCT/US2005/38821, dated Mar. 3, 2006, 3 pages. |
| IOVS, 1999, 40 (4), S535. |
| Kiely et al., “The mean shape of the human comea,” Optica ACTA, 1982, 29 (8), 1027-1040. |
| Kokoschka S., et al., “Influence of Field Size on the Spectral Sensitivity of the Eye in the Photopic and Mesopic Range,” American Journal of Optometry and Physiological Optics, 1985, vol. 62 (2), pp. 119-126. |
| Liang J., et al, “Objective Measurement of Wave Aberrations of the Human Eye With the Use of a Hartmann-Shack Wave-Front Sensor,” Journal of the Optical Society of America, 1994, vol. 11 (7), pp. 1949-1957. |
| Lindsay R., et al., “Descriptors of Corneal Shape,” Optometry and Vision Science, 1998, vol. 75 (2), pp. 156-158. |
| Lotmar, “Theoretical eye model with aspherics,” Journal of the Optical Society of America, 1971, 61 (11), 1522-1529. |
| Malacara D., et al., “Wavefront Fitting With Discrete Orthogonal Polynomials in a Unit Radius Circle,” Optical Engineering, 1990, vol. 29 (6), pp. 672-675. |
| Mandell R.B., et al., “Mathematical Model of the Corneal Contour,” 1965, School of Optometry, University of Califomia, Berkeley, pp. 183-197. |
| Marcos S., et al., “A New Approach to the Study of Ocular Chromatic Aberrations,” Vision Research, 1999, vol. 39 (26), pp. 4309-4323. |
| Mordi J.A., et al., “Influence of Age of Chromatic Aberration of the Human Eye,” American Journal of Optometry & Physiological Optics, 1985, vol. 62 (12), pp. 864-869. |
| Navarro R., et al., “Accommodation-Dependent Model of the Human Eye with Aspherics,” Journal of the Optical Society of America, Aug. 1985, vol. 2 (8), pp. 1273-1281. |
| Norrby S., et al., “Model Eyes for Evaluation of Intraocular Lenses,” Applied Optics, Sep. 7, 2007, vol. 46 (26), pp. 6595-6605. |
| Office Action dated Jul. 5, 2011 for Japanese Application No. 2007539132 filed Oct. 25, 2005. |
| “Optical Design,” Military Standardization Handbook, 1962, Chapter 4, U.S. Department of Defense MIL-HDBK-141, 4-1-4-19. |
| Oshika T., et al., “Changes in Corneal Wavefront Aberrations with Aging,” Investigative Ophthalmology & Visual Science, 1999, vol. 40 (7), pp. 1351-1355. |
| Patel S., et al., “Shape and Radius of Posterior Corneal Surface,” Refractive and Corneal Surgery, 1993, vol. 9 (3), pp. 173-181. |
| Piers P.A., et al., “Theoretical Comparison of Aberration-Correcting Customized and Aspheric Intraocular Lenses,” Journal of Refractive Surgery, Apr. 2007, vol. 23 (4), pp. 374-384. |
| Said et al., “The Variation with Age of the Spectral Transmissivity of the Living Human Crystalline Lens,” Gerontologia, 1959, 213-231. |
| Alfonso J.F., et al., “Prospective Study of the Acri.LISA Bifocal Intraocular Lens,” Journal of Cataract Refractive Surgery, Nov. 2007, vol. 33 (11), pp. 1930-1935. |
| Canovas C., et al., “Hybrid Adaptive-Optics Visual Simulator,” Optical Letters, Jan. 15, 2010, vol. 35 (2), pp. 196-198. |
| Diffractive Lenses for Extended Depth of Focus and Presbyopic Correction, Presentation from Wavefront Congress held on Feb. 15, 2008, Rochester, New York. |
| Doskolovich L.L., et al., “Special Diffractive Lenses,” Lens and Optical Systems Design, Apr. 1992, vol. 1780, pp. 393-402. |
| Liou H.L., et al., “Anatomically Accurate, Finite Model Eye for Optical Modeling,” Journal of Optical Society of America, Aug. 1997, vol. 14 (8), pp. 1684-1695. |
| Marsack J.D., et al., “Metrics of Optical Quality Derived from Wave Aberrations Predict Visual Performance,” Journal of Vision, Apr. 2004, vol. 4 (4), pp. 322-328. |
| Monsoriu J.A., et al., “Devil's Lenses,” Optics Express, Oct. 17, 2007, vol. 15 (21), pp. 13858-13864. |
| Morlock, R., et al., “Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and Validation,” American Journal of Ophthalmology, Jun. 2017, vol. 178, pp. 101-114. |
| Piers P.A., et al., “Eye Models for the Prediction of Contrast Vision in Patients with New Intraocular Lens Designs,” Optics Letters, Apr. 1, 2004, vol. 29 (7), pp. 733-735. |
| Siedlecki D., et al., “Radial Gradient index Intraocular Lens: a Theoretical Model,” Journal of Modern Optics, Feb. 20-Mar. 10, 2008, vol. 55 (4-5), pp. 639-647. |
| Terwee T., et al., “Visualization of the Retinal Image in an Eye Model With Spherical and Aspheric, Diffractive, and Refractive Multifocal Intraocular Lenses,” Journal of Refractive Surgery, Mar. 2008, vol. 24 (3), pp. 223-232. |
| Van Den Berg T.J., “Analysis of Intraocular Straylight, Especially in Relation to Age,” Optometry and Vision Science Feb. 1995, vol. 72 (2), pp. 52-59. |
| Van Meeteren A., “Calculations on the Optical Modulation Transfer Function of the Human Eye for White Light,” Optica Acta, May 1974, vol. 21 (5), pp. 395-412. |
| Villegas E.A., et al., “Correlation between Optical and Psychophy, Sical Parameters as a Function of Defocus,” Optometry and Vision Science, Jan. 1, 2002, vol. 79 (1), pp. 60-67. |
| Castignoles F., et al., “Comparison of the Efficiency, MTF and Chromatic Properties of Four Diffractive Bifocal Intraocular Lens Designs,” Optics Express, Mar. 2010, vol. 18 (5), pp. 5245-5256. |
| Sokolowski M., et al. “Hybrid Heptafocal Intraocular Lenses, ” Optica Applicata, Dec. 2015, vol. 45 (3), pp. 285-298. |
| Number | Date | Country | |
|---|---|---|---|
| 20190171036 A1 | Jun 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61695806 | Aug 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14014701 | Aug 2013 | US |
| Child | 15149574 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15149574 | May 2016 | US |
| Child | 16252157 | US |
